Organon & Co. financial data

Symbol
OGN on NYSE
Location
Jersey City, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 172% % 4.5%
Quick Ratio 54% % 12%
Debt-to-equity 1710% % -59%
Return On Equity 26% % -91%
Return On Assets 1.4% % -80%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 260,315,650 shares 0.14%
Common Stock, Shares, Outstanding 260,316,000 shares 0.98%
Entity Public Float $2,500,000,000 USD -53%
Common Stock, Value, Issued $3,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 259,495,000 shares 0.95%
Weighted Average Number of Shares Outstanding, Diluted 260,764,000 shares 0.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,216,000,000 USD -2.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $425,000,000 USD -47%
Income Tax Expense (Benefit) $238,000,000 USD 185%
Net Income (Loss) Attributable to Parent $187,000,000 USD -78%
Earnings Per Share, Basic 0.72 USD/shares -79%
Earnings Per Share, Diluted 0.72 USD/shares -78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $574,000,000 USD -15%
Accounts Receivable, after Allowance for Credit Loss, Current $1,331,000,000 USD -2%
Inventory, Net $1,406,000,000 USD 6.4%
Other Assets, Current $1,033,000,000 USD 3.9%
Assets, Current $4,352,000,000 USD 0.09%
Property, Plant and Equipment, Net $1,303,000,000 USD 12%
Operating Lease, Right-of-Use Asset $155,000,000 USD -1.3%
Intangible Assets, Net (Excluding Goodwill) $1,130,000,000 USD -20%
Goodwill $4,153,000,000 USD -11%
Assets $12,867,000,000 USD -1.8%
Accounts Payable, Current $952,000,000 USD -17%
Liabilities, Current $2,390,000,000 USD -12%
Deferred Income Tax Liabilities, Net $57,000,000 USD -23%
Operating Lease, Liability, Noncurrent $116,000,000 USD 3.6%
Other Liabilities, Noncurrent $1,008,000,000 USD 3.2%
Liabilities $12,115,000,000 USD -4.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $527,000,000 USD 19%
Retained Earnings (Accumulated Deficit) $1,109,000,000 USD 9.8%
Stockholders' Equity Attributable to Parent $752,000,000 USD 59%
Liabilities and Equity $12,867,000,000 USD -1.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $75,000,000 USD -1.3%
Net Cash Provided by (Used in) Financing Activities $75,000,000 USD -1.4%
Net Cash Provided by (Used in) Investing Activities $172,000,000 USD -79%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 260,316,000 shares 0.98%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $128,000,000 USD -8.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $574,000,000 USD -15%
Deferred Tax Assets, Valuation Allowance $310,000,000 USD 19%
Deferred Tax Assets, Gross $1,370,000,000 USD 5.6%
Operating Lease, Liability $156,000,000 USD 0%
Depreciation $34,000,000 USD 6.2%
Payments to Acquire Property, Plant, and Equipment $32,000,000 USD -30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $309,000,000 USD -59%
Lessee, Operating Lease, Liability, to be Paid $176,000,000 USD -0.56%
Operating Lease, Liability, Current $40,000,000 USD -9.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $41,000,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year One $47,000,000 USD -4.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.055 pure 7.8%
Deferred Income Tax Expense (Benefit) $17,000,000 USD -440%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,000,000 USD -4.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three $35,000,000 USD 25%
Deferred Tax Assets, Operating Loss Carryforwards $229,000,000 USD 2.2%
Unrecognized Tax Benefits $160,000,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid, Year Four $20,000,000 USD 11%
Deferred Tax Assets, Net of Valuation Allowance $1,060,000,000 USD 2.3%
Share-based Payment Arrangement, Expense $77,000,000 USD -27%
Interest Expense $504,000,000 USD -3.1%